🔗 Share this article

An underground market for unlicensed weight-loss medications is being driven by TikTok fitness influencers and vendors on messaging platforms, according to new investigations.

Experimental Treatment Gaining Popularity Online

The experimental drug, which is still in clinical trials, is being promoted by social media influencers for its supposed weight-reducing properties. Followers are encouraged to message these profiles directly for source information, while also receiving discount codes.

Active Commerce on Social Networks

Separately, a flourishing trade exists on messaging services, where groups with thousands of members share comparison photos, administration instructions and claims of next-day British shipping. Sellers market the drug there before directing customers to other platforms for purchases.

Understanding The Experimental Drug

This medication is an experimental injectable created by American pharmaceutical company Eli Lilly. The treatment targets three intestinal hormones – GLP-1, GIP and glucagon. Preliminary studies indicate it could help individuals reduce up to a quarter of their total weight. Nicknamed the “triple G”, the drug is being promoted digitally as the successor to Ozempic.

Healthcare Experts Voice Worries

Nevertheless, doctors and chemists have warned that the distribution of what remains an unapproved drug in the UK is a cause for concern and could lead to individuals injecting products of uncertain source.

Several experts stated the popularity for retatrutide could be connected to the rising cost of licensed slimming treatments such as Mounjaro.

Regulatory Status and Implementation

Selling the unapproved drug on social media or messaging apps is prohibited in the UK, as it is an unapproved drug that must not be promoted or distributed for human use under the British medical regulations.

Several content creators attempt to circumvent the regulations by referring to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled drug, but advertising and supply can still breach pharmaceutical, marketing, and customer regulations, potentially leading to fines, prosecution or imprisonment.

Service Reaction and Material Elimination

According to TikTok, the platform has taken down violative material and prohibited related keywords and query recommendations. The organization said it was dedicated to maintaining the platform secure and allocating resources in enhancing enforcement strategies.

Online Marketplace Activities

Research also found groups with up to nine thousand members marketing the experimental drug using the platform's built-in discovery tool, which operates like a public directory. Typing “retatrutide” instantly displays groups with thousands of members, populated with images of slimming results, positive reviews and step-by-step guides for mixing or injecting at residence.

Within moments of entering one community, a seller posted WhatsApp details, where the majority of transactions occur. The seller sent an guidebook and promised shipping within two days. When asked whether the substance was genuine, one vendor said: “You can’t be sure.” Another provided a photo of a supposed laboratory certificate. None inquired about weight, medical conditions or previous experience.

Product Details and Pricing

Within these groups, messages display black plastic parcels with postal service stickers, claiming to include new batches. One communication stated: “It took eight of us to load them this morning.”

Customers can choose between dry substance containers, mixed at residence with purified liquid, or ready-to-use injectors usually sold at £160 for 20mg. When asked how long a pen should be used, sellers give contradictory answers varying between a several days to “depends on your body”.

Service Moderation and Security Measures

A spokesperson for the messaging service stated it regularly monitored dangerous content on its service including content that promoted the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.

Medical Expert Warnings

“Individuals are administering materials they cannot confirm. Although the science behind retatrutide is valid, these digital products may not include what they claim,” said Jason Murphy, the director of pharmacy at Chemist4U.

Dr Crystal Wyllie of an online medical service connected the increase in interest to recent cost increases for authorized weight-loss drugs such as Mounjaro. “With costs rising, individuals are turning to social media. But fake treatments are extremely risky. You cannot know what’s inside or whether the conditions they were produced in was sterile,” she explained.

Her team has already encountered individuals injured by personal administration from unconfirmed sources. “We understand the disappointment, but buying from messaging apps or WhatsApp is gambling with your health,” stated Wyllie. “These materials could be contaminated or incorrectly dosed.”

Manufacturer Position

A representative from Eli Lilly stated the substance was in phase 3 clinical trials and had not been evaluated or approved by any government authority globally. “Therefore at this point no one can sell [it] for personal consumption,” they said, noting that any product “falsely representing itself as a Lilly experimental substance not yet approved … may subject patients to potentially serious health risks”.